Literature DB >> 15001403

A comparison of phenytoin-loading techniques in the emergency department.

Stuart P Swadron1, Maria I Rudis, Kian Azimian, Paul Beringer, Diana Fort, Michael Orlinsky.   

Abstract

OBJECTIVES: To compare the effectivenesses of three phenytoin-loading techniques.
METHODS: Patients with subtherapeutic phenytoin concentrations who presented within 48 hours of a seizure were randomized to receive either 20 mg/kg of oral phenytoin (PO), divided in maximum doses of 400 mg every two hours, 18 mg/kg of intravenous phenytoin (IVP) at an initial infusion rate of 50 mg/min, or 18 mg/kg (phenytoin equivalents) of intravenous fosphenytoin (IVF) at an initial infusion rate of 150 mg/min.
RESULTS: A total of 45 patients were enrolled: 16 in the PO group, 14 in the IVP group, and 15 in the IVF group. The times required to reach therapeutic drug concentrations were (mean +/- standard deviation [SD]) 5.62 +/- 0.28 hours, 0.24 +/- 0.3 hours, and 0.21 +/- 0.28 hours, respectively. A total of 17, 27, and 32 adverse drug events were observed in the PO, IVP, and IVF groups, respectively, with significantly fewer events in the PO group (p = 0.02, p = 0.01). No significant difference was found between the numbers of necessary adjustments to the infusions in the two IV groups. The average time to safe emergency department discharge was significantly shorter for the IV groups compared with the PO group (p < 0.001).
CONCLUSIONS: Oral loading has fewer adverse drug events than either IV loading method, but its use may be limited when therapeutic concentrations are required quickly. Although IVF loading is faster, from an adverse-drug event perspective, no advantage of IVF over IVP was apparent.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15001403     DOI: 10.1111/j.1553-2712.2004.tb02204.x

Source DB:  PubMed          Journal:  Acad Emerg Med        ISSN: 1069-6563            Impact factor:   3.451


  13 in total

Review 1.  Refractory generalised convulsive status epilepticus : a guide to treatment.

Authors:  Reetta Kälviäinen; Kai Eriksson; Ilkka Parviainen
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

Review 2.  Generalised convulsive status epilepticus: an overview.

Authors:  R Nandhagopal
Journal:  Postgrad Med J       Date:  2006-11       Impact factor: 2.401

3.  Intravenous phenytoin: a retrospective analysis of Bayesian forecasting versus conventional dosing in patients.

Authors:  Andrea Tobler; Stefan Mühlebach
Journal:  Int J Clin Pharm       Date:  2013-06-29

Review 4.  Cardiovascular adverse effects of phenytoin.

Authors:  B Guldiken; J Rémi; Soheyl Noachtar
Journal:  J Neurol       Date:  2015-12-08       Impact factor: 4.849

5.  IV fosphenytoin in obese patients: Dosing strategies, safety, and efficacy.

Authors:  Sarah L Clark; Megan R Leloux; Ross A Dierkhising; Gregory D Cascino; Sara E Hocker
Journal:  Neurol Clin Pract       Date:  2017-02

6.  Cost-effectiveness analysis of intravenous levetiracetam versus intravenous phenytoin for early onset seizure prophylaxis after neurosurgery and traumatic brain injury.

Authors:  Rashid Kazerooni; Mark Bounthavong
Journal:  Clinicoecon Outcomes Res       Date:  2010-03-05

7.  Fosphenytoin for the treatment of status epilepticus: an evidence-based assessment of its clinical and economic outcomes.

Authors:  Andrew Thomson
Journal:  Core Evid       Date:  2005-03-31

8.  Predictors of Outcome in Children with Status Epilepticus during Resuscitation in Pediatric Emergency Department: A Retrospective Observational Study.

Authors:  Indumathy Santhanam; Sangeetha Yoganathan; V Akila Sivakumar; Rubini Ramakrishnamurugan; Sharada Sathish; Murali Thandavarayan
Journal:  Ann Indian Acad Neurol       Date:  2017 Apr-Jun       Impact factor: 1.383

9.  Efficacy of levetiracetam versus fosphenytoin for the recurrence of seizures after status epilepticus.

Authors:  Kensuke Nakamura; Ryota Inokuchi; Hiroaki Daidoji; Hiromu Naraba; Tomohiro Sonoo; Hideki Hashimoto; Kurato Tokunaga; Takahiro Hiruma; Kent Doi; Naoto Morimura
Journal:  Medicine (Baltimore)       Date:  2017-06       Impact factor: 1.889

10.  Levetiracetam vs. Fosphenytoin for Second-Line Treatment of Status Epilepticus: Propensity Score Matching Analysis Using a Nationwide Inpatient Database.

Authors:  Kensuke Nakamura; Hiroyuki Ohbe; Hiroki Matsui; Yuji Takahashi; Aiki Marushima; Yoshiaki Inoue; Kiyohide Fushimi; Hideo Yasunaga
Journal:  Front Neurol       Date:  2020-07-02       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.